abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund managed by abrdn Inc. The fund invests in public equity markets globally, focusing on the life sciences sector. This includes companies in biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, and devices and supplies. The fund also invests in the agriculture and environmental management industries. It primarily targets growth stocks of small-cap companies. The investment strategy involves fundamental analysis, evaluating factors such as market position for products or services, the experience of business management, technological expertise, and the ability to finance growth internally or secure external capital. The fund benchmarks its performance against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992, and is domiciled in the United States.